Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)

NCT02622659 is registered in ClinicalTrials.gov with Guangzhou Yipinhong Pharmaceutical CO.,LTD as lead sponsor.

NCT NCT02622659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02622659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)
Lead sponsor
Guangzhou Yipinhong Pharmaceutical CO.,LTD
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2012
Completion date
March 31, 2014
Enrollment
468 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute upper respiratory infection